Abstract:Aim: Visceral obesity is a key risk factor in the development of oesophagogastric junctional adenocarcinoma (OGJ), predominantly via generation of systemic low grade inflammation. Obesity-induced inflammation promotes resistance to current standards of care, enhancing tumour cell growth and survival. This study investigates the effect of the visceral adipose tissue secretome from OGJ patients with early versus advanced tumours on T-cell immunity and the role of immune checkpoint blockade in enhancing anti-tumour immunity. Methods and results: Visceral adipose conditioned media (ACM) from both early and late-stage OGJ patients significantly altered T cell activation status, upregulating co-stimulatory marker CD27 on T cells. ACM from both early and late-stage OGJ patients significantly altered immune checkpoint expression profiles downregulating immune checkpoints (ICs) on the surface of dual Th1/17-like and Th17-like cells and upregulating ICs on the surface of Th1-like cells and Treg cells. ACM derived from early-stage OGJ patients but not late-stage OGJ patients increased IFN-γ production by T cells. The addition of immune checkpoint blockers (ICBs) did not increase IFN-γ production by T cells in the presence of late-stage ACM, collectively highlighting the dichotomous immunostimulatory effect of early-stage ACM and immune-inhibitory effect of late-stage ACM. Interestingly, ACM from early-stage OGJ patients was more pro-inflammatory than ACM from late-stage patients, reflected by decreased levels of IL-17A/F, TNF-α, IL-1RA and IL-5. Conclusion: The ACM-induced upregulation of ICs on T cells highlights a therapeutic vulnerability that could be exploited by ICBs to harness anti-cancer immunity and improve clinical outcomes for OGJ patients. Schematic workflow - (A) visceral adipose tissue was taken from OAC patients at time of surgery and cultured for 72 h in media. (B) The harvested ACM was co-cultured with healthy donor PBMCs that were concurrently activated with anti-CD3/28 for 48 h and T cell immunophenotyping was carried out by flow cytometry. Key findings - (A) Early and late stage ACM enhanced a Th1-like phenotype and upregulated CTLA-4 on Th1-like cells. A Th17-like phenotype was also enhanced in addition with a Treg-like phenotype. CTLA-4 and PD-L1 were upregulated on the surface of Treg-like cells. (B) ICB-attenuated IL-17 production by T cells. However, ACM attenuated ICB-mediated reduction in IL-10 production by T cells. Higher levels of pro-inflammatory factors were found in early stage ACM compared with late stage ACM.

Comparative analysis of protein expression between oesophageal adenocarcinoma and normal adjacent tissue

Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma

Comparative Proteomic Analysis to Investigate the Pathogenesis of Oral Adenoid Cystic Carcinoma

High-content profiling reveals a unified model of copper ionophore dependent cell death in oesophageal adenocarcinoma

Proteomic analysis enables distinction of early- versus advanced-stage lung adenocarcinomas

Understanding the immuno-biology of oesophageal adenocarcinoma: Towards improved therapeutic approaches

Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy

Comparative Proteomic Analysis of Esophageal Squamous Cell Carcinoma

Comparative analysis of transcriptomic and proteomic expression between two non-small cell lung cancer subtypes

Genomic Analysis of HPV-positive Versus HPV-negative Oesophageal Adenocarcinoma Identifies a Differential Mutational Landscape.

On-chip Raman spectroscopy of live single cells for the staging of oesophageal adenocarcinoma progression

Tumour microenvironment influences response to treatment in oesophageal adenocarcinoma

Comparative Transcriptome Characterization of Esophageal Squamous Cell Carcinoma and Adenocarcinoma.

PS02.241: SINGLE CELL RNA SEQUENCING REVEALS THE HETEROGENEITY OF NON-CANCER CELL POPULATIONS WITHIN THE ECOSYSTEM OF ESOPHAGEAL ADENOCARCINOMA

Proteomic Analysis of Human Esophageal Cancer Using Tandem Mass Tag Quantifications

Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells

Massively Parallel Reporter Assays identify enhancer elements in Oesophageal Adenocarcinoma.

Label-free tissue proteomics can classify oral squamous cell carcinoma from healthy tissue in a stage-specific manner

Current status of proteomics of esophageal carcinoma

Olink Proteomics-Based Exploration of Immuno-Oncology-Related Biomarkers Leading to Lung Adenocarcinoma Progression

Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery